Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacob M Rowe

Showing results (31-40 of 275) with videos related to

Pageof 28
Sort By:
Best Practice & Research. Clinical Haematology|December 1, 2011
Evaluation of prognostic factors in AML. PrefaceJacob M Rowe
Haematologica|November 2, 2020
Forward into the second century of HaematologicaJacob M Rowe
Current Opinion in Hematology|January 20, 2011
Induction and postremission strategies in acute myeloid leukemia: what is new?Yishai Ofran, Jacob M Rowe
Current Opinion in Hematology|January 12, 2018
Revisiting autologous transplantation in acute myeloid leukemiaChezi Ganzel, Jacob M Rowe
Hematology/Oncology Clinics of North America|December 3, 2014
Transplantation in acute myeloid leukemiaTsila Zuckerman, Jacob M Rowe
Current Opinion in Hematology|October 18, 2003
Acute lymphocytic leukemia: role of hematopoietic stem cell transplantation in current managementIrit Avivi, Jacob M Rowe
Hematology/Oncology Clinics of North America|November 19, 2011
Prognostic factors in adult acute leukemiaChezi Ganzel, Jacob M Rowe
Blood|April 18, 2013
Gemtuzumab ozogamicin in acute myeloid leukemia: a remarkable saga about an active drugJacob M Rowe, Bob Löwenberg
Leukemia & Lymphoma|June 12, 2012
Total ambulatory hemato-oncological care: a myth or reality?Chezi Ganzel, Jacob M Rowe
Current Opinion in Hematology|January 10, 2012
Treatment for relapsed acute myeloid leukemia: what is new?Yishai Ofran, Jacob M Rowe
Pageof 28

Showing results (31-40 of 275) with videos related to

Sort By:
Pageof 28
Best Practice & Research. Clinical Haematology|December 1, 2011
Evaluation of prognostic factors in AML. PrefaceJacob M Rowe
Haematologica|November 2, 2020
Forward into the second century of HaematologicaJacob M Rowe
Current Opinion in Hematology|January 20, 2011
Induction and postremission strategies in acute myeloid leukemia: what is new?Yishai Ofran, Jacob M Rowe
Current Opinion in Hematology|January 12, 2018
Revisiting autologous transplantation in acute myeloid leukemiaChezi Ganzel, Jacob M Rowe
Hematology/Oncology Clinics of North America|December 3, 2014
Transplantation in acute myeloid leukemiaTsila Zuckerman, Jacob M Rowe
Current Opinion in Hematology|October 18, 2003
Acute lymphocytic leukemia: role of hematopoietic stem cell transplantation in current managementIrit Avivi, Jacob M Rowe
Hematology/Oncology Clinics of North America|November 19, 2011
Prognostic factors in adult acute leukemiaChezi Ganzel, Jacob M Rowe
Blood|April 18, 2013
Gemtuzumab ozogamicin in acute myeloid leukemia: a remarkable saga about an active drugJacob M Rowe, Bob Löwenberg
Leukemia & Lymphoma|June 12, 2012
Total ambulatory hemato-oncological care: a myth or reality?Chezi Ganzel, Jacob M Rowe
Current Opinion in Hematology|January 10, 2012
Treatment for relapsed acute myeloid leukemia: what is new?Yishai Ofran, Jacob M Rowe
Pageof 28